Prediction of Neoadjuvant Chemotherapy Response in Pancreatic Cancer

NCT07226154 · clinicaltrials.gov ↗

RECRUITING

Status

200

Enrollment

OTHER

Sponsor class

Conditions

Pancreatic Ductal Adenocarcinoma

Interventions

DIAGNOSTIC_TEST: Small RNA sequencing
DIAGNOSTIC_TEST: PRECEPT assay (qRT-PCR validation)

Sponsor

City of Hope Medical Center